Literature DB >> 14973222

ETR-3 and CELF4 protein domains required for RNA binding and splicing activity in vivo.

Gopal Singh1, Nicolas Charlet-B, Jin Han, Thomas A Cooper.   

Abstract

Members of the CUG-BP and ETR-3 like factor (CELF) protein family bind within conserved intronic elements (called MSEs) flanking the cardiac troponin T (cTNT) alternative exon 5 and promote exon inclusion in vivo and in vitro. Here we use a comparative deletion analysis of two family members (ETR-3 and CELF4) to identify separate domains required for RNA binding and splicing activity in vivo. CELF proteins contain two adjacent RNA binding domains (RRM1 and RRM2) near the N-terminus and one RRM (RRM3) near the C-terminus, which are separated by a 160-230 residue divergent domain of unknown function. Either RRM1 or RRM2 of CELF4 are necessary and sufficient for binding MSE RNA and RRM2 plus an additional 66 amino acids of the divergent domain are as effective as full-length protein in activating MSE-dependent splicing in vivo. Non-overlapping N- and C-terminal regions of ETR-3 containing either RRM1 and RRM2 or RRM3 plus segments of the adjacent divergent domain activate MSE-dependent exon inclusion demonstrating an unusual functional redundancy of the N- and C-termini of the protein. These results identify specific regions of ETR-3 and CELF4 that are likely targets of protein-protein interactions required for splicing activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14973222      PMCID: PMC373409          DOI: 10.1093/nar/gkh275

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

Review 1.  Alternative splicing: increasing diversity in the proteomic world.

Authors:  B R Graveley
Journal:  Trends Genet       Date:  2001-02       Impact factor: 11.639

2.  Initial sequencing and analysis of the human genome.

Authors:  E S Lander; L M Linton; B Birren; C Nusbaum; M C Zody; J Baldwin; K Devon; K Dewar; M Doyle; W FitzHugh; R Funke; D Gage; K Harris; A Heaford; J Howland; L Kann; J Lehoczky; R LeVine; P McEwan; K McKernan; J Meldrim; J P Mesirov; C Miranda; W Morris; J Naylor; C Raymond; M Rosetti; R Santos; A Sheridan; C Sougnez; Y Stange-Thomann; N Stojanovic; A Subramanian; D Wyman; J Rogers; J Sulston; R Ainscough; S Beck; D Bentley; J Burton; C Clee; N Carter; A Coulson; R Deadman; P Deloukas; A Dunham; I Dunham; R Durbin; L French; D Grafham; S Gregory; T Hubbard; S Humphray; A Hunt; M Jones; C Lloyd; A McMurray; L Matthews; S Mercer; S Milne; J C Mullikin; A Mungall; R Plumb; M Ross; R Shownkeen; S Sims; R H Waterston; R K Wilson; L W Hillier; J D McPherson; M A Marra; E R Mardis; L A Fulton; A T Chinwalla; K H Pepin; W R Gish; S L Chissoe; M C Wendl; K D Delehaunty; T L Miner; A Delehaunty; J B Kramer; L L Cook; R S Fulton; D L Johnson; P J Minx; S W Clifton; T Hawkins; E Branscomb; P Predki; P Richardson; S Wenning; T Slezak; N Doggett; J F Cheng; A Olsen; S Lucas; C Elkin; E Uberbacher; M Frazier; R A Gibbs; D M Muzny; S E Scherer; J B Bouck; E J Sodergren; K C Worley; C M Rives; J H Gorrell; M L Metzker; S L Naylor; R S Kucherlapati; D L Nelson; G M Weinstock; Y Sakaki; A Fujiyama; M Hattori; T Yada; A Toyoda; T Itoh; C Kawagoe; H Watanabe; Y Totoki; T Taylor; J Weissenbach; R Heilig; W Saurin; F Artiguenave; P Brottier; T Bruls; E Pelletier; C Robert; P Wincker; D R Smith; L Doucette-Stamm; M Rubenfield; K Weinstock; H M Lee; J Dubois; A Rosenthal; M Platzer; G Nyakatura; S Taudien; A Rump; H Yang; J Yu; J Wang; G Huang; J Gu; L Hood; L Rowen; A Madan; S Qin; R W Davis; N A Federspiel; A P Abola; M J Proctor; R M Myers; J Schmutz; M Dickson; J Grimwood; D R Cox; M V Olson; R Kaul; C Raymond; N Shimizu; K Kawasaki; S Minoshima; G A Evans; M Athanasiou; R Schultz; B A Roe; F Chen; H Pan; J Ramser; H Lehrach; R Reinhardt; W R McCombie; M de la Bastide; N Dedhia; H Blöcker; K Hornischer; G Nordsiek; R Agarwala; L Aravind; J A Bailey; A Bateman; S Batzoglou; E Birney; P Bork; D G Brown; C B Burge; L Cerutti; H C Chen; D Church; M Clamp; R R Copley; T Doerks; S R Eddy; E E Eichler; T S Furey; J Galagan; J G Gilbert; C Harmon; Y Hayashizaki; D Haussler; H Hermjakob; K Hokamp; W Jang; L S Johnson; T A Jones; S Kasif; A Kaspryzk; S Kennedy; W J Kent; P Kitts; E V Koonin; I Korf; D Kulp; D Lancet; T M Lowe; A McLysaght; T Mikkelsen; J V Moran; N Mulder; V J Pollara; C P Ponting; G Schuler; J Schultz; G Slater; A F Smit; E Stupka; J Szustakowki; D Thierry-Mieg; J Thierry-Mieg; L Wagner; J Wallis; R Wheeler; A Williams; Y I Wolf; K H Wolfe; S P Yang; R F Yeh; F Collins; M S Guyer; J Peterson; A Felsenfeld; K A Wetterstrand; A Patrinos; M J Morgan; P de Jong; J J Catanese; K Osoegawa; H Shizuya; S Choi; Y J Chen; J Szustakowki
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

3.  A genomic view of alternative splicing.

Authors:  Barmak Modrek; Christopher Lee
Journal:  Nat Genet       Date:  2002-01       Impact factor: 38.330

4.  The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing.

Authors:  A N Ladd; N Charlet; T A Cooper
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

5.  Genomic organization and isoform-specific tissue expression of human NAPOR (CUGBP2) as a candidate gene for familial arrhythmogenic right ventricular dysplasia.

Authors:  D Li; L L Bachinski; R Roberts
Journal:  Genomics       Date:  2001-06-15       Impact factor: 5.736

6.  CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms.

Authors:  N A Timchenko; A L Welm; X Lu; L T Timchenko
Journal:  Nucleic Acids Res       Date:  1999-11-15       Impact factor: 16.971

7.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

8.  A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator.

Authors:  P J Good; Q Chen; S J Warner; D C Herring
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

9.  The CUG-binding protein binds specifically to UG dinucleotide repeats in a yeast three-hybrid system.

Authors:  N Takahashi; N Sasagawa; K Suzuki; S Ishiura
Journal:  Biochem Biophys Res Commun       Date:  2000-10-22       Impact factor: 3.575

10.  Human cardiac troponin T: identification of fetal isoforms and assignment of the TNNT2 locus to chromosome 1q.

Authors:  P J Townsend; H Farza; C MacGeoch; N K Spurr; R Wade; R Gahlmann; M H Yacoub; P J Barton
Journal:  Genomics       Date:  1994-05-15       Impact factor: 5.736

View more
  19 in total

1.  Transcription-coupled and splicing-coupled strand asymmetries in eukaryotic genomes.

Authors:  Marie Touchon; Alain Arneodo; Yves d'Aubenton-Carafa; Claude Thermes
Journal:  Nucleic Acids Res       Date:  2004-09-23       Impact factor: 16.971

Review 2.  The role of CELF proteins in neurological disorders.

Authors:  Jean-Marc Gallo; Carl Spickett
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

3.  Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment.

Authors:  Nuno André Faustino; Thomas A Cooper
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 4.  The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins.

Authors:  Twishasri Dasgupta; Andrea N Ladd
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-08-17       Impact factor: 9.957

5.  Chromatin and Transcriptional Analysis of Mesoderm Progenitor Cells Identifies HOPX as a Regulator of Primitive Hematopoiesis.

Authors:  Nathan J Palpant; Yuliang Wang; Brandon Hadland; Rebecca J Zaunbrecher; Meredith Redd; Daniel Jones; Lil Pabon; Rajan Jain; Jonathan Epstein; Walter L Ruzzo; Ying Zheng; Irwin Bernstein; Adam Margolin; Charles E Murry
Journal:  Cell Rep       Date:  2017-08-15       Impact factor: 9.423

6.  Upregulation of cugbp2 increases response of pancreatic cancer cells to chemotherapy.

Authors:  Aldona Jakstaite; Aurelija Maziukiene; Giedre Silkuniene; Kristina Kmieliute; Albertas Dauksa; Saulius Paskauskas; Antanas Gulbinas; Zilvinas Dambrauskas
Journal:  Langenbecks Arch Surg       Date:  2015-12-21       Impact factor: 3.445

7.  Cardiac tissue-specific repression of CELF activity disrupts alternative splicing and causes cardiomyopathy.

Authors:  Andrea N Ladd; George Taffet; Craig Hartley; Debra L Kearney; Thomas A Cooper
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

8.  Muscleblind proteins regulate alternative splicing.

Authors:  Thai H Ho; Nicolas Charlet-B; Michael G Poulos; Gopal Singh; Maurice S Swanson; Thomas A Cooper
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

9.  CUG-BP, Elav-like family member 1 (CELF1) is required for normal myofibrillogenesis, morphogenesis, and contractile function in the embryonic heart.

Authors:  Yotam Blech-Hermoni; Connor B Sullivan; Michael W Jenkins; Oliver Wessely; Andrea N Ladd
Journal:  Dev Dyn       Date:  2016-05-31       Impact factor: 3.780

10.  Position-dependent and neuron-specific splicing regulation by the CELF family RNA-binding protein UNC-75 in Caenorhabditis elegans.

Authors:  Hidehito Kuroyanagi; Yohei Watanabe; Yutaka Suzuki; Masatoshi Hagiwara
Journal:  Nucleic Acids Res       Date:  2013-02-14       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.